Bray Capital Advisors Merck & Co., Inc. Transaction History

Bray Capital Advisors

  • $394 Million
  • Q3 2024

A detailed history of Bray Capital Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bray Capital Advisors holds 39,606 shares of MRK stock, worth $3.96 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
39,606
Previous 40,338 1.81%
Holding current value
$3.96 Million
Previous $4.99 Million 9.93%
% of portfolio
1.14%
Previous 1.29%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$111.15 - $128.97 $81,361 - $94,406
-732 Reduced 1.81%
39,606 $4.5 Million
Q2 2024

Jul 31, 2024
SELL
$123.8 - $132.96 $55,338 - $59,433
-447 Reduced 1.1%
40,338 $4.99 Million
Q1 2024

Apr 30, 2024
SELL
$113.24 - $131.95 $27,517 - $32,063
-243 Reduced 0.59%
40,785 $5.38 Million
Q4 2023

Jan 29, 2024
BUY
$100.18 - $109.02 $19,535 - $21,258
195 Added 0.48%
41,028 $4.47 Million
Q3 2023

Oct 27, 2023
SELL
$102.95 - $114.33 $8,338 - $9,260
-81 Reduced 0.2%
40,833 $4.2 Million
Q2 2023

Jul 28, 2023
SELL
$108.61 - $118.38 $158,679 - $172,953
-1,461 Reduced 3.45%
40,914 $4.72 Million
Q1 2023

Apr 28, 2023
SELL
$102.94 - $114.86 $56,411 - $62,943
-548 Reduced 1.28%
42,375 $4.51 Million
Q4 2022

Jan 20, 2023
SELL
$87.44 - $112.11 $171,032 - $219,287
-1,956 Reduced 4.36%
42,923 $0
Q3 2022

Nov 21, 2022
SELL
$84.53 - $94.96 $7,100 - $7,976
-84 Reduced 0.19%
44,879 $3.87 Million
Q2 2022

Aug 01, 2022
BUY
$83.49 - $94.64 $30,223 - $34,259
362 Added 0.81%
44,963 $4.1 Million
Q1 2022

May 03, 2022
SELL
$73.51 - $82.4 $17,421 - $19,528
-237 Reduced 0.53%
44,601 $3.66 Million
Q4 2021

Jan 31, 2022
BUY
$72.28 - $90.54 $60,498 - $75,781
837 Added 1.9%
44,838 $3.44 Million
Q3 2021

Oct 28, 2021
BUY
$71.68 - $78.83 $27,883 - $30,664
389 Added 0.89%
44,001 $3.31 Million
Q2 2021

Jul 28, 2021
BUY
$70.31 - $77.77 $286,302 - $316,679
4,072 Added 10.3%
43,612 $3.39 Million
Q1 2021

May 03, 2021
BUY
$68.86 - $81.11 $124,430 - $146,565
1,807 Added 4.79%
39,540 $3.05 Million
Q4 2020

Jan 28, 2021
BUY
$71.77 - $79.65 $111,028 - $123,218
1,547 Added 4.28%
37,733 $3.09 Million
Q3 2020

Oct 30, 2020
BUY
$73.18 - $82.95 $42,517 - $48,193
581 Added 1.63%
36,186 $3 Million
Q2 2020

Jul 28, 2020
SELL
$70.42 - $80.13 $43,871 - $49,920
-623 Reduced 1.72%
35,605 $2.75 Million
Q1 2020

May 01, 2020
BUY
$63.36 - $87.82 $380 - $526
6 Added 0.02%
36,228 $2.79 Million
Q4 2019

Jan 31, 2020
SELL
$77.58 - $87.54 $12,645 - $14,269
-163 Reduced 0.45%
36,222 $3.29 Million
Q3 2019

Oct 29, 2019
SELL
$76.08 - $82.93 $193,167 - $210,559
-2,539 Reduced 6.52%
36,385 $3.06 Million
Q2 2019

Jul 29, 2019
SELL
$69.84 - $81.59 $54,545 - $63,721
-781 Reduced 1.97%
38,924 $3.26 Million
Q1 2019

Apr 30, 2019
SELL
$69.58 - $79.36 $6,470 - $7,380
-93 Reduced 0.23%
39,705 $3.3 Million
Q4 2018

Feb 15, 2019
SELL
$65.24 - $75.71 $22,768 - $26,422
-349 Reduced 0.87%
39,798 $3.04 Million
Q3 2018

Oct 31, 2018
SELL
$57.69 - $67.84 $1,557 - $1,831
-27 Reduced 0.07%
40,147 $2.85 Million
Q2 2018

Jul 31, 2018
BUY
$50.83 - $59.72 $46,611 - $54,763
917 Added 2.34%
40,174 $2.44 Million
Q1 2018

May 04, 2018
BUY
$50.96 - $59.23 $182,182 - $211,747
3,575 Added 10.02%
39,257 $2.14 Million
Q4 2017

Feb 02, 2018
SELL
$51.62 - $61.64 $143,555 - $171,420
-2,781 Reduced 7.23%
35,682 $2.01 Million
Q3 2017

Nov 01, 2017
BUY
$58.67 - $63.13 $2.26 Million - $2.43 Million
38,463
38,463 $2.46 Million

Others Institutions Holding MRK

# of Institutions
3,828
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bray Capital Advisors Portfolio

Follow Bray Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bray Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Bray Capital Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email